Drawing for NUCLEIX

USPTO serial 88549443

NUCLEIX

Reviewed by CopyMark Law Group

Reg. 6208606Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
SABAGH, LAILA TAREK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NUCLEIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Sheehan Anderson

Jennifer Sheehan Anderson BRIDGE INTELLECTUAL PROPERTY SERVICES143 CadyCenter, Suite 209Northville, MI 48167UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory useACTIVE—
005Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection; diagnostic reagents for medical purposesACTIVE—
010Apparatus for medical diagnostic testing in the field of cancerACTIVE—
042Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assaysACTIVE—
044Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and prognosis of expected progression of the disease; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer; providing cancer screening services; providing a website featuring information in the fields of the diagnosis and treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 16, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 16, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 16, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 16, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 16, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 13, 2020OTHECASE RETURNED TO EXAMINATION—
Aug 11, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 3, 2020TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Aug 3, 2020PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Aug 3, 2020APETASSIGNED TO PETITION STAFF—
Aug 3, 202044EP44(e) PETITION - RECEIVED—
Apr 16, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE—
Apr 16, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 18, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Feb 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 17, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 5, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2019DOCKASSIGNED TO EXAMINER—
Aug 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance